This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sueoka, E. Articles by Fujiki, H. Search for Related Content PubMed PubMed Citation Articles by Sueoka, E. Articles by Fujiki, H.

Heterogeneous Nuclear Ribonucleoprotein B1 as Early Cancer Biomarker for Occult Cancer of Human Lungs and Bronchial Dysplasia¹

Saitama Cancer Center Research Institute [E. S., N. S., Y. G., S. M., H. F.] and Saitama Cancer Center Hospital [H. N.], Saitama 362-0806; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575 [M. S., S. F.]; and Department of Oral and Maxillofacial Surgery, Tokyo Medical University, Shinjuku, Tokyo 160-8402 [Y. G., H. C.], Japan

Heterogeneous nuclear ribonucleoprotein (hnRNP) B1 is a RNA-binding protein of M_r 37,000. We previously reported that hnRNP B1 was specifically overexpressed in the nuclei of human lung cancer cells, particularly in squamous cell carcinoma (E. Sueoka et al., Cancer Res., 59: 1404–1407, 1999). We extended this study to determine whether hnRNP B1 was overexpressed in roentgenographically occult cancers of the lungs and premalignant lesions of squamous cell carcinomas, such as bronchial dysplasia. The additional object of our study was to examine the usefulness of hnRNP B1 as a potential diagnostic marker for squamous cell carcinoma of various organs, such as the oral cavity and esophagus in humans. Surgically resected specimens of bronchial dysplasia, lung cancers, and various human squamous cell carcinomas, collected at two hospitals in Japan, were subjected to immunohistochemical staining with anti-hnRNP B1 antibody. Overexpression of hnRNP B1 protein was observed in 100% of stage I lung cancer tissues, but it was not found in normal bronchial epithelium. Squamous cell carcinoma of the lungs showed stronger staining than other histological types, and elevation of hnRNP B1 was found in both roentgenographically occult lung cancers and bronchial dysplasia. Furthermore, cytological examination with anti-hnRNP B1 antibody detected cancer cells in sputum, suggesting the potential of hnRNP B1 protein as a new biomarker for the very early stage of lung cancer in humans. Because strong staining of hnRNP B1 was also observed in various squamous cell carcinomas of oral and esophageal tissues as shown in our recent reports, overexpression of hnRNP B1 seems to be a common event in the carcinogenic processes of squamous cell carcinoma. These results suggest that hnRNP B1 protein could be a useful diagnostic biomarker for both the very early stages of lung cancer and various squamous cell carcinomas in humans.

This article has been cited by other articles:

				S. KATSIMPOULA, M. PATRINOU-GEORGOULA, N. MAKRILIA, K. DIMAKOU, A. GUIALIS, D. ORFANIDOU, and K.N. SYRIGOS Overexpression of hnRNPA2/B1 in Bronchoscopic Specimens: A Potential Early Detection Marker in Lung Cancer Anticancer Res, April 1, 2009; 29(4): 1373 - 1382. [Abstract] [Full Text] [PDF]

				L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097. [Abstract] [Full Text] [PDF]

				Y. He, M. A. Brown, J. A. Rothnagel, N. A. Saunders, and R. Smith Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation J. Cell Sci., July 15, 2005; 118(14): 3173 - 3183. [Abstract] [Full Text] [PDF]

				K. Moran-Jones, L. Wayman, D. D. Kennedy, R. R. Reddel, S. Sara, M. J. Snee, and R. Smith hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere Nucleic Acids Res., January 19, 2005; 33(2): 486 - 496. [Abstract] [Full Text] [PDF]

				F B J M Thunnissen Sputum examination for early detection of lung cancer J. Clin. Pathol., November 1, 2003; 56(11): 805 - 810. [Abstract] [Full Text] [PDF]

				C. A. Powell, A. Spira, A. Derti, C. DeLisi, G. Liu, A. Borczuk, S. Busch, S. Sahasrabudhe, Y. Chen, D. Sugarbaker, et al. Gene Expression in Lung Adenocarcinomas of Smokers and Nonsmokers Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 157 - 162. [Abstract] [Full Text] [PDF]

				J. M. Kurie Cyclin D1 Expression in the Field of Exposure: Another Piece in the Molecular Auerbach Puzzle J. Clin. Oncol., June 1, 2003; 21(11): 2056 - 2058. [Full Text] [PDF]

				M. Itoh, I. Haga, Q.-H. Li, and J.-i. Fujisawa Identification of cellular mRNA targets for RNA-binding protein Sam68 Nucleic Acids Res., December 15, 2002; 30(24): 5452 - 5464. [Abstract] [Full Text] [PDF]

				F.R. Hirsch, D.T. Merrick, and W.A. Franklin Role of biomarkers for early detection of lung cancer and chemoprevention Eur. Respir. J., June 1, 2002; 19(6): 1151 - 1158. [Abstract] [Full Text] [PDF]